Arcturus expands collaboration, adding $30M cash; Kura shoots for $100M raise
→ Rare disease player Ultragenyx $RARE is expanding its alliance with Arcturus $ARCT, paying $24 million for equity and another $6 million …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
